Moxalactam

Moxalactam (Latamoxef) is a synthetic oxa-β-lactam antibiotic. Moxalactam has a broad spectrum of activity against Gram-positive and Gram-negative aerobic and anaerobic bacteria. Moxalactam inhibits production of β-lactamases[1].

Product Specifications

CAS Number

[64952-97-2]

Product Name Alternative

Latamoxef; Lamoxactam; LY-127935

UNSPSC

12352005

Hazard Statement

H302-H312-H332

Target

Antibiotic; Bacterial; Beta-lactamase

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/moxalactam.html

Solubility

10 mM in DMSO

Smiles

O=C(C(N12)=C(CSC3=NN=NN3C)CO[C@]2([H])[C@](OC)(NC(C(C(O)=O)C4=CC=C(O)C=C4)=O)C1=O)O

Molecular Formula

C20H20N6O9S

Molecular Weight

520.47

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P363-P501

References & Citations

[1]Carmine AA, et al. Moxalactam (latamoxef) . A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1983 Oct;26 (4) :279-333.|[2]Goto S. In vitro and in vivo antibacterial activity of moxalactam, an oxa-β-lactam antibiotic. Clinical Infectious Diseases, 1982, 4 (Supplement_3) : S501-S510.